Attachment 1 - RFI Statement of Work (DRAFT) National Urinalysis Testing and Support Services 10.29.24.pdf

Statement of Work (DRAFT)

US Courts On-site Drug Laboratory

C.1 BACKGROUND

18 U.S.C. Section 3154 and 3672 provides the Director of the Administrative Office of the U.S. Courts (AOUSC) with the authority to contract with public or private agencies for the detection and care of alcohol or drug dependent persons or those with psychiatric disorders, to include the authority to contract for necessary testing of those individuals.

In accordance with 18 U.S.C. Section 3154 and 3672, persons under investigation or the supervision of the Federal Probation and Pretrial Services system in the contiguous United States, Alaska, Hawaii, Puerto Rico, Guam, and the Virgin Islands may be required to participate in a comprehensive urine testing program to determine the presence and abuse of drugs. Initial screening of specimens may be conducted at on-site district laboratories located in Government facilities nationwide. These facilities may be within either federal courthouses or General Services Administration (GSA) contracted space.

C.2 PURPOSE

To provide equipment, supplies, training and consumables required to operate an instrumented screening urine testing facility that will support the United States Probation and Pretrial Services Offices on-site laboratories (herein after on-site laboratories) located in the contiguous United States, Alaska, Hawaii, Puerto Rico, Guam, and Virgin Islands.

C.3 GENERAL REQUIREMENTS/PROJECT SCOPE

C. 3.1 This contract is intended to provide automated analyzers, forensic use immunoassay reagents, controls, calibrators, all supplies and consumables necessary to operate the analyzers; maintenance of the analyzers; training; water systems; quality control, and a data management system with the capability to export results to all on-site laboratories (regardless of each laboratory's individual testing volume) to operate on-site district drug testing laboratories (as approved by the IDIQ COR). On-site laboratories will issue specified task orders (TO) for reagent purchases which will be issued against this master indefinite delivery/indefinite quantity (IDIQ) contract.

C.3.2 The contractor shall cover all costs of initial installation of new equipment for all laboratories under the contract. The contractor shall provide all the necessary equipment to meet the testing needs of each laboratory based on the volumes of testing as specified in Section C.5.2.1, Performance of Equipment. All costs shall be rolled into the fixed-price per-test reagent as specified in Attachment 1.

Therefore, the government shall not be charged separately for the equipment (i.e., analyzer(s), water system(s), data management system and any hardware and software, including software licenses), quality control, and maintenance nor shall the government be charged for any delivery or installation costs, or travel.

C. 3.3 During the term of this IDIQ contract, laboratories and/or equipment may be added or removed at the Government's discretion. This would be communicated to the contractor by the IDIQ COR. The cost of installing equipment in a new laboratory, moving equipment from one location to another within an existing laboratory, or removing equipment due to the closing of a laboratory shall be invoiced directly to the on-site laboratory contracting officer, and not rolled into the fixed-price per-test reagent cost. The cost related to the installation of new laboratory equipment, moving equipment from one location to another within an existing laboratory or closing of a laboratory shall include all associated costs, to include but not limited to shipment, installation, decontamination, training, and travel

C. 3.4 This master IDIQ contract may be used by individual on-site laboratories located nationwide.

C.3.5 Unless otherwise stated, all provisions that follow throughout the remaining sections of this master contract may be revised within the overall scope of the contract, as necessary (based on the need and regulations of the agency).

C.4 GEOGRAPHICAL AREA

The contractor shall provide drug analyzing equipment, on-site urinalysis testing equipment, and supplies to on-site laboratories within the contiguous United States, Alaska, Hawaii, Puerto Rico, Guam, and the Virgin Islands.

Within 60 days of the Indefinite Delivery Indefinite Quantity (IDIQ) award kick-off meeting, the contractor shall deliver new equipment and provide training to each district with an on-site laboratory.

There are 14 probation and pretrial offices with on-site district urinalysis testing equipment that require an initial installation. (Reference Attachment 2, for a listing of approved on-site laboratories). As these facilities are located within either federal courthouses or GSA contracted space, which is secure, there may be additional steps required in scheduling the delivery of the equipment and training. The contractor shall not be held responsible for delays caused by the Government or due to scheduling issues related to required modifications to space and/or facilities.

C.5 DRUG TESTING EQUIPMENT AND REAGENTS

The contractor shall ensure that all equipment provided and installed meets or exceeds the requirements stated herein to analyze specimens accurately and efficiently over the life of the contract.

C.5.1 Automatic Analyzer

a) The contractor shall be allowed to provide different size analyzers. However, each analyzer must have the appropriate through-put to meet the volume requirements identified in C.5.4 for each on-site laboratory. The selection of the size and number of analyzers may vary based on the space considerations of the on-site laboratory.

b) The contractor shall provide any water system(s) needed to operate the instrument. The selection of the type and size of the water system may vary based on the space, water, and drain considerations of the on-site laboratory.

i. As part of any water purification system, the contractor shall provide a moisture sensing device that will detect moisture and stop the water supply at its source in the event of a leak, to prevent water damage.

ii. The automated analyzer provided shall be capable of providing quantitative creatinine levels in urine as identified in C.5.6.

C.5.2 Equipment

a) The contractor shall provide the government with new equipment at the initial installation of each on-site laboratory which tests and analyzes the drugs listed in C.5.5 and is operational and supported in accordance with section C.5.4.

b) In the event there is a need for replacement of any equipment, the contractor shall submit, in writing, the specifications and delivery information to the IDIQ COR and Ordering Contracting Officer (CO) for approval, no later than ten (10) calendar days prior to planned installation.

C.5.2.1 Performance of Equipment

a) The contractor shall provide all the required equipment to meet the testing needs of each on-site laboratory. The contractor shall provide equipment that is capable of testing specimens based on the following volume and testing requirements:

i. No less than 400 tests per hour for sites conducting between 5,000 and 13,000 tests per month;

ii. No less than 600 tests per hour for sites conducting between 13,000 and 25,000 tests per month.

iii. For sites conducting over 25,000 tests per month the contractor shall provide a primary analyzer capable of testing no less than 800 tests per hour and a backup analyzer based on the volume of testing and the approval of the IDIQ CO.

b) The contractor shall provide analyzers that are able to produce qualitative (Defined in Section C.5.4, Quality Control) as well as semi-quantitative results for all drugs tested.

c) The contractor shall provide software (including licenses) and software updates to meet the needs of each on-site laboratory, as approved by the IDIQ COR.

d) The contractor shall provide technical support and maintenance including preventive and remedial maintenance to ensure continual proper operations of the equipment.

C.5.2.2 Equipment Failure

e) The contractor shall ensure that all equipment in laboratories shall be returned to operating condition in accordance with Original Equipment Manufacturer (OEM) standards and shall not be inoperable for more than seven (7) calendar days unless approved in writing by the COR. If the contractor fails to provide resolution at the government's site within the seven (7) calendar day requirement, the on-site laboratory shall contact the IDIQ COR for resolution assistance.

a) All repairs, parts, labor, and transportation costs shall be at the expense of the contractor (pricing is incorporated into the price-per-test cost).

b) If equipment is not operable and needs to be replaced due to an inability to repair the equipment to operating condition in accordance with OEM, the contractor shall provide new equipment to replace the inoperable equipment. In the event the contractor cannot timely provide new equipment due to delivery delays, the contractor is authorized to provide refurbished equipment until the new equipment is able to be delivered and installed. These considerations would be made on a case-by-case basis and under direct consultation with the IDIQ COR, with all expense on the contractor (pricing is incorporated into the price-per-test cost).

c) If equipment failure or damage is a result of the contractors’ failure to perform or negligence in performing repairs, the contractor shall provide repair or replacement at its expense or, if repaired or replaced at agency expense, the contractor shall reimburse the agency for losses attributable to the contractor’s failure or negligence.

C.5.2.3 Maintenance and Response Times

a) The contractor shall establish a point of contract (name, phone number, and e-mail address) for use by the on-site laboratories in providing response to contractor equipment failures.

b) The government has a twenty-four (24) hour response requirement whereby the contractor shall respond either by telephone or email to the requesting government official.

c) The response time starts after the government's first bona fide attempt to contact the contractor either by email or telephone that remedial maintenance or repair is required.

d) The contractor shall provide preventative maintenance at each on-site laboratory for the analyzer(s) and water system(s) a minimum of twice per year.

e) All maintenance, repairs, parts, labor, and transportation costs shall be at the expense of the contractor (pricing is incorporated into the price-per-test cost).

f) If a site visit is needed to repair equipment, repair personnel shall arrive on site within two business days for emergency/nonemergency repairs. The contractor shall have access during normal business hours, however, at the discretion of the on-site laboratory, may be granted 24-hour per day access.

g) Emergency maintenance and repair work is defined as maintenance or repair necessary to correct an existing or imminent failure to meet the Original Equipment Manufacturer (OEM) standards.

C.5.2.4 Escalation Procedures

The contractor shall have escalation procedures in place in case the contractor is unable to return the equipment to proper operating condition within the required response time. A copy of these procedures shall be provided to the Government upon award. In conjunction with the contractor, the Government reserves the right to add, delete or modify these procedures if necessary.

C.5.3 Certification of Drug Testing Equipment

Contractor supplied equipment shall meet federal regulatory requirements to test for the presence of drugs of abuse. All equipment shall be commercially available. The equipment shall be capable of using reagents cleared for forensic use, FDA cleared, or FDA approved.

C.5.4 Quality Control

a) The contractor will perform random tests and inspections, at least annually, to ensure that the contractor provided equipment meets the quality control standard throughout the duration of the contract.

i. For those tests being run qualitatively, quality controls at levels 25% above and below the cut-off should be correct at least 95% of the time.

ii. For tests run semi-quantitatively, quality controls at levels 25% above and below the cut-off should be used and ranges should be set to +/- 2 S.D.'s (standard deviations), based on the Levy Jennings values over multiple runs.

iii. Manufacturer supplied ranges can be used as initial guidelines. However, each lab should establish their own ranges and can use supplied ranges from the manufacturer as initial ranges.

C.5.5 Drug Testing Reagents

a) The contractor shall provide ready-to-use liquid reagents to use to test for specified drugs of abuse at the specified cutoff levels set below.

i. At a minimum, the reagents provided by the contractor shall meet forensic use standards for testing at the prescribed cutoff levels identified below.

ii. The contractor may obtain the required cutoff levels using an assay/reagent in the qualitative analyses or semi-quantitative analyses (for example via customized calibration with analyzer validations) of the specified drug.

iii. The results may be obtained using an assay in the qualitative analyses or semi-quantitative analyses, to meet the specified cutoff levels, for all drugs listed.

b) The contractor shall provide non-liquid reagents with prior approval in writing by the Ordering CO, when ready-to-use liquid reagents are not available.

c) The contractor shall supply bio-hazard information and Material Safety Data Sheets for all reagents and ancillary supplies, at delivery; and provide as part of the training specific bio-safety issues regarding specimen and reagent handling.

d) Unopened reagents shall be stable for one year from date of receipt, when stored, refrigerated, or as specified by the manufacturer, and stable for at least 12 weeks once opened and stored as specified by the manufacturer.

e) The contractor shall utilize overnight shipping for all refrigerated items. The contractor shall not ship refrigerated items on Friday, Saturdays, or the day prior to a federal holiday. All shipping costs shall be rolled into the fixed-price per-test reagent cost.

f) The contractor shall ship non-refrigerated consumables within 2 business days of the order placement by the on-site laboratory. All shipping costs shall be rolled into the fixed-price per-test reagent cost.

C.5.5.1 Assay Chart

ASSAY DESCRIPTION CUTOFF LEVELS

1) Cannabinoids 50 ng/mL

2) Cocaine Metabolite 150 ng/mL

3) Opiates (Based on 300 ng/mL of morphine) 300 ng/mL

4) Amphetamines (Based on 500 ng/mL d-methamphetamine, but should be able to detect amphetamine, MDMA and MDA at clinical concentrations)

500 ng/mL

5) Benzodiazepines (Based on 200 ng/mL of oxazepam or another equivalent benzodiazepine)

200 ng/mL

6) Creatinine

Normal: >20 mg/dL

Dilute: 2-20 mg/dL

Substituted: <2mg/dL

7) Methadone 300 ng/mL

8) Oxycodone 100 ng/mL

9) Buprenorphine 5 ng/mL

10) Barbiturates 200 ng/mL

11) 6 AM 10 ng/mL

12) Fentanyl 1 ng/mL

13) Ethyl Glucuronide (EtG) 500 mg/mL

14) Ketamine TBD

15) Psilocybin TBD

C.6 INFORMATION TECHNOLOGY SUPPORT

The Drug Test Results Component (DTR) of the Federal Judiciary’s Probation and Pretrial Services Automated Case Tracking System (PACTS) tracks drug tests and drug test results in support of Pretrial Services and Probation Offices within the U.S. Court System. DTR utilizes and electronic interface with the on-site laboratories to automatically received and process results of test performed. The Federal

Judiciary is in the beginning phase of replacing its current PACTS system. The new system will be installed and operation sometime during the performance period of the IDIQ.

The contractor's drug testing system shall include a data management system with a user interface that accepts specimen identification and test specifications. The data management system shall be capable of storing the data elements specified in Attachment 3 - Specification for Probation and Pretrial Case Tracking System (PACTS) Drug Testing Results (DTR) Component On-Site Laboratory(s) Interface.

The contractor and the government shall share technical information (i.e, Analyzer Specifications, Database Information, Interface requirements, Security Considerations, Regulatory Compliance, Development Environment) to enable the AOUSC to build a software interface between the analyzer database and PACTS.

a) The contractor's system shall provide features that affect the current and future ability of the system to accommodate evolving reporting needs including ease of customization of the database fields and reports; the data export features of the software; and the compatibility of the system on a network (Reference Attachment 3 – Specification for Probation and Pretrial Case Tracking System (PACTS) Drug Testing Results (DTR) Component On-Site Laboratory(s) Interface).

b) The contractor shall provide the hardware and software systems, training, and support, and develop procedures to implement automatic results transfers as outlined in Attachment 3.

c) The contractor shall identify a technical point of contact to assist in resolving the results-transfer problems.

d) The contractor shall provide technical assistance to each on-site laboratory and/or the Administrative Office as needed for troubleshooting and establishing connectivity with the contractor's system.

C.6.2 Quality Controls

The Contractor(s) Quality controls of the contractor's systems shall include, but are not limited to, security, archival capabilities, historical data analysis, calibrator and controls results tracking, and Levey- Jennings quality control charts, which shall be used to plot laboratory quality control results.

a) The contractor and on-site laboratory personnel shall use these quality control graphs and tracking information to determine and correct errors or problems.

b) All test data shall be archived for a minimum of two years and up to five years for certain data (e.g., quality control data, and blind proficiency test data).

c) The system shall support user input of test data, storage of test results data, and export of data to an independent computer system.

C.6.3 Data Management System

a) The contractor shall provide a data management system that is web based and contains at a minimum the database fields, elements, functions, and reports described in Attachment 3 and C.6.4 of this contract.

b) The data management system shall be compatible with the analyzers and the equipment of each on-site laboratory.

c) The data management system shall include the hardware (central processing unit (CPU), monitor, bar-code scanner and printer) and necessary software.

d) The data management system shall:

i. Electronically record the results of each assay;

ii. Read bar-coded specimens;

iii. Report and electronically transmit individual test results, quantitative when appropriate, from the database to remote locations within 2 hours of acceptance of the test results;

iv. Produce customized aggregate reports of test results in user-defined categories.

C.6.4 Data Management Reports

a) The contractor shall provide access to the following reports to the IDIQ COR by the 10th of each month on activities of the prior month to include the raw data used for these reports in Microsoft Excel or XML format. Graphical representations shall not be provided with the raw data. The IDIQ COR will be responsible for final approval of the format and data layout of the monthly reports provided to the IDIQ COR. The contractor shall also provide access to monthly/ad hoc reports, at no additional cost to the government, in electronic format as requested by the IDIQ COR. All reports may be modified as deemed appropriate by the IDIQ COR and the contractor.

The contractor shall provide the IDIQ reports by the 10th of each month to include the following:

(1) On-Site Drug Testing Financial Report (within 10 days of the start of each quarter): This report shall list a running monthly expenditure of assays by: (a) each ordering district,

(b) per on-site laboratory, and (c) nationwide. The contractor shall arrange the On-Site Drug Testing Financial Report by each fiscal year.

(2) Monthly Lab Summary Report Breakdown per On-Site Laboratory (each month): This report shall include: (a) the date range for the report; (b) name of on-site laboratory; (c) a itemization of each district site providing samples to the on-site laboratory with the number of samples and tests completed per office; and (d) a monthly cumulative total of the number of tests and samples per each on-site laboratory.

(3) Monthly Cumulative Lab Summary Report (each month): This report shall include: (a) the date range of the report; and (b) a monthly cumulative total of tests and samples completed per on-site laboratory sorted by month and year. The contractor shall arrange the Cumulative Lab Summary Report by each fiscal year.

b) The contractor shall provide the following reports within 5 business days of request by the IDIQ

COR:

(1) Positive Results by Assay Report: This report shall list (a) all positive sample results by each ordering district, (b) the percentage of positive sample results, (c) numbers of positive tests by assay, (d) number of donors with positive results; (e) if diluted, (f) test date, and (g) report date.

(2) Positive Results Trend Report: This is a monthly central report of positive results by district and nationwide that shall include: (a) the number of donors; (b) the number of requisitions (samples); (c) the number of positive results; (d) the percentage of requisitions (samples) that tested positive (i.e. percent positivity rate for samples); and

(e) the percent positivity rate by assay.

(3) District Trend Reports: This report shall include: (a) the monthly number of requisitions (samples) by district and collection site; (b) the number of tests by district and collection site. At the Government's discretion, the contractor shall produce a nationwide trend analysis of the national number of tested specimens from month to month, year to year, and over the life of this contract.

(4) Diluted Specimen Report: This report shall list: (a) all diluted specimens by on-site laboratory and collection site; (b) if result was positive or negative and for which analyte, (c) test date, and (d) report date. The report shall summarize the monthly data in table format, by collection site and on-site laboratory, and nationwide, and include the following fields: (g) the number of requisitions; (h) the number of diluted specimens; (I) the percentage of diluted specimens; (j) the number of diluted specimens that were positive; and (k) the percentage of diluted requisitions (specimens) that were positive.

c) The contractor shall provide all on-site laboratories, under the contract, the capability to run the following reports locally for data belonging to their individual laboratory:

i. On-Site Drug Testing Financial Report,

ii. Positive Results by Drug Class Report,

iii. Quality Control Reports, and

iv. Diluted Specimen Report.

C.7 TRAINING

The contractor shall be responsible for providing all training within the terms of the contract. All training materials and class schedules shall be coordinated with the on-site laboratory prior to the scheduling and delivery of all training. The contractor shall provide training that includes, all aspects of the on-site testing, specifically the instruments (analyzers), reagents and database training. The contractor shall provide a remote or virtual annual training refresher course sufficient to maintain certification.

C.7.1 Training Program

a) Within 7-days of the installation of the laboratory equipment and instruments, the contractor shall conduct a two-part certification training session for all laboratory personnel as follows:

i. Technical instruction on how to use and maintain the equipment and reagents, and

ii. Administrative instruction on how to use the data management system. Training on the data management system may include additional district personnel.

This training shall be coordinated and conducted in conjunction with the delivery and installation of equipment and supplies to each on-site laboratory location.

b) The contractor shall provide the certification training at either the on-site district laboratories or at a mutually agreed upon central location. The training location is at the discretion of the contractor; however, conducting training at the on-site laboratory is available. Should the contractor choose to conduct the training (required for certified operation of the equipment) at an off-site location, the contractor shall be responsible for all training and costs incurred for the training of those selected judiciary designated operators and back up personnel.

c) During the term of this contract, the contractor may be required to provide additional certification training to Judiciary personnel who did not receive the initial two-part training session as stated above. Training shall be completed within 30 days of notification to the contractor by the on-site laboratory of the new laboratory staff needing certification training.

d) The contractor shall promptly notify the IDIQ COR of any training requests received directly from the on-site laboratories.

e) All training prices are rolled into the fixed price per reagent.

C.7.2 Certification Training Requirements

At a minimum, the contractor provided certification training shall meet the following requirements:

a. Training shall cover the following elements: drug immunoassay and validity testing reagents; instrumentation; and laboratory database management/interface with court’s database systems.

b. Training shall include certification of each operator by the trainer of successful completion of training and demonstration of competence through the performance of actual testing operations.

c. Reagents. Training on the use of the immunoassay reagents shall include the following:

i. Basics of immunoassay drug detection including antibody specificity/cross-reactivity;

ii. Immunoassay detection mechanism for the technology being proposed;

iii. Cutoffs, how are they established;

iv. Package insert information;

v. Interpretation of test results;

vi. Reagent handling (including any possible biohazard issues and specimen handling), storage and stability; and

vii. Training on the use of validity testing reagents and interpretation of results.

d. Instrumentation. Training on the use of the immunoassay reagents and validity test reagents on each type of proposed analyzers shall include the following:

i. Instrument environmental requirements (e.g., temperature, humidity);

ii. Basic instrument operations, including daily start-up and shut down procedures;

Calibration and control operations;

iii. Programming, data entry/load list;

iv. Reading and interpretation of raw data test results;

v. Quality control practices;

vi. Running proficiency test specimens;

vii. Maintenance and troubleshooting operations;

viii. Actual drug and validity testing operations using drug testing immunoassay and validity testing reagents; and

ix. Training on any necessary ancillary instrumentation such as water purification systems if needed.

e. Laboratory Database Management System and Interface. Training on the test system database management and its interface with the US Court’s systems shall include the following:

i. Transfer of data from chain of custody forms into laboratory database management system;

ii. Transfer of data from analyzer to laboratory database management system;

iii. Preparation of reports, including drug and validity test results, periodic statistical summary reports, and quality control reports;

iv. Preparation of customized reports;

v. Provision of reports through both hard-copy means as well as digitally transmitted means;

vi. Archival operations (test, calibration, and control data); and

vii. Security of data and data transmissions.

C.7.3 Conferences

Every other year, the contractor shall be required to attend and present at the On-Site Laboratory Conference, through coordination with the IDIQ COR. The presence of the contractor at the conference would not exceed two business days. All travel and lodging expenses associated with attendance at the conference shall be the financial responsibility of the contractor and shall be factored into the fixed-price per-test reagent.

C.7.4 Web-based/Virtual Training

Once a year, the Contractor shall provide web-based/virtual training for the on-site laboratories regarding trends on drugs of abuse and refresher training for the analyzers, reagents, and data management system. This training shall be provided live for the on-site laboratories with an opportunity for questions and answers; however, it should also be recorded and available electronically to the Judiciary. All training costs shall be factored into the proposed fixed-price per-test reagent.

C.8 INITIAL DELIVERY AND INSTALLATION OF EQUIPMENT/SUPPLIES

The contractor shall deliver all equipment and supplies and provide training to the Probation and Pretrial Services offices identified in Attachment 2 of the contract no-later-than 60-days after the kick-off meeting and within 3 business days of the removal of the incumbent’s equipment, unless alternate arrangements are coordinated and approved, in writing with the IDIQ COR.

The contractor is required to coordinate the delivery and installation of equipment, supplies, and service of equipment with the on-site laboratories. As these facilities are located within either federal courthouses or GSA contracted space, which is secure, there will be additional steps required in the scheduling of the above items. The contractor will not be held responsible for delays caused by the Government or due to scheduling issues related to required facility or space modifications (if required).

The contractor shall provide written notification to IDIQ COR of the delivery and installation date for each on-site laboratory to include the type of analyzer(s) and water system(s) that will be installed.

Additionally, the contractor shall provide written notification to the IDIQ COR within five business days after installation and training has been completed for each on-site laboratory.

C.9 CONTRACT TRANSITION

C.9.1 PHASE-IN

The contractor shall provide a 60-day phase-in plan five days after award of the IDIQ contract to include:

1. Kick-off meeting for IDIQ

2. Equipment delivery and installation plan

3. Training Plan

4. Assay and consumable ordering procedures

C.9.2 PHASE-OUT

At the expiration of this contract and if the government selects a "successor" contractor to provide the services performed under this contract, the incumbent contractor (hereto now referred as the "Incumbent") shall minimize the transfer of services risks by developing and implementing a comprehensive phase-out plan. The phase-out plan shall include the appointment of a formal phase-out team to interact with the government and the successor contractor. The incumbent shall minimize service disruptions to the government during the exit process by remaining fully staffed and maintaining quality work performance until the final date of the contract. The incumbent's phase-out plan shall include working with both the government and successor contractor to coordinate the removal and de-installation of the incumbent's equipment and supplies and the delivery and installation of the successor contractor's equipment and supplies in a manner that minimizes service disruptions at each on-site district laboratory. As a means to provide a smooth transition and continued operation of services, the incumbent's transition plan shall include, at a minimum, the following:

(1) 90-day plan / schedule for the orderly de-installation of equipment and supplies;

(2) Identify transition staff and responsibilities, and provide a POC list for coordination with the successor contractor;

(3) This schedule and POC list shall be provided to the COR within fourteen (14) calendar days of new contract award;

(4) Bi-weekly status reports detailing the progress of the transition, including both formal and informal reporting procedures; and

(5) The out-going contractor shall ensure the completion of a full data transfer to the government or successor contractor for all sites at the direction of the COR at no additional cost to the government.

C.10 KICK-OFF MEETING

The contractor shall meet with the IDIQ CO and the IDIQ COR to discuss the IDIQ contract objectives no later than fifteen (15) days after the date of contract award. This kick-off meeting may be held at the government's facility located in Washington, DC or held virtually as determined by the IDIQ CO.

KEY PERSONNEL

Project Manager

The Project Manager is to serve as the point-of-contact for the IDIQ COR and Contracting Officer (CO) and shall be able to manage all aspects of the contract and resolve any issues for the IDIQ and each order placed. The Project Manager shall: (a) be available to discuss and resolve all administrative and technical issues related to the administration and delivering the supplies and services under the terms of the contract, and (b) ensure that the contractor's local representative(s) adhere to the requirements of the contract. The Project Manager shall respond to telephonic or electronic communication from the IDIQ COR and/or CO within two (2) hours via similar communication means. If the Project Manager resides in a time zone other than the Eastern Standard Time Zone, then all telephonic or electronic communications received outside of the Project Managers local business hours shall be responded to within two (2) hours of the start of business for that time zone, which is defined as 8:30 AM for this contract.

The Project Managers qualifications are: 1) shall have a minimum of five (5) years’ experience in managing projects similar in size and scope outlined in sections C.3, C.4, and C.5 in this statement of work; and 2) shall have a demonstrated knowledge and experience of drug testing for the drugs outlined in section C.5.5.

Field Customer Service Representative

The Field Customer Service Representative(s) shall serve as the contractor’s technical representative who provides a single point-of-contact for all on-site laboratories for all questions and technical support. The Field Customer Service Representative(s) shall possess a minimum of two (2) years’ experience in providing technical support to multiple test sites with demonstrated knowledge and experience of drug testing for the drugs outlined in section C.5.5.